Companies /Healthcare

Tempus AI, Inc. Class A Common Stock

NASDAQ: TEM Health Information Services
$70.43
▼ $5.18 (−6.85%) today
Markets closed · 6:56am ET

24/7 Wall St. View

Price Prediction $87.95 +16.3% Our analysts’ 12-month view: target, optimistic case, and floor. TEM price prediction → Earnings Beat +191.5% EPS vs. the estimate, revenue, and how the market reacted. TEM earnings history →

TEM at a Glance

Valuation
Market cap
$12.8B
Profitability
Revenue (TTM)
$1.5B
Profit margin
-12.5%
EPS (TTM)
$-1.06
Price
52-week range
$41 – $89
24/7 target
$87.95
Street target
$80.61
Earnings
Q3 2026 EPS
$0.07
vs. $-0.08 est.
+191.5%

Headquartered in Chicago, IL Fiscal year ends December NASDAQ: TEM tempus.com

About Tempus AI

Tempus AI is a technology company applying artificial intelligence to precision medicine. It operates through two segments.

- **Diagnostics:** Oncology genomic profiling, Minimal Residual Disease (MRD) testing, hereditary testing through Ambry Genetics, and FDA-cleared AI cardiology tools such as Tempus ECG-PH and ECG-MR.
- **Data and Applications:** Licensing of de-identified multimodal data and AI models to pharmaceutical and biotech companies, including its Insights offering, plus clinical workflow and trial-matching applications.

The company maintains one of the world's largest libraries of de-identified multimodal clinical and molecular data and an intelligent operating system connecting AI, diagnostics and clinical workflows. Its data customers include BMS, Pathos AI (a related party), and Merck and Moderna, with a 2026 collaboration supporting commercialization of an individualized neoantigen therapy.

Tempus has expanded through acquisitions including Paige AI, Ambry Genetics, Deep 6 AI and Center Health, and has a pending acquisition of Personalis. It is also building a 100,000-whole-genome research platform linked to longitudinal clinical data. Updated

Revenue by Segment · Q3 2026
  1. Diagnostics74%
  2. Data and Applications26%

Latest Activity

Biggest movers · At the close
Gainers
  • IDXXIDEXX Laboratories$671.82+21.9%
  • TEMTempus AI$79.36+9.9%
  • RIVNRivian$13.1+7.7%
  • HWMHowmet Aerospace$212.78+6.8%
  • BAMBrookfield Asset Management$51.37+6.4%
Losers
  • LITELumentum$683.66-18.7%
  • MRVLMarvell Technology$171.11-12.9%
  • ALABAstera Labs$229.63-11.2%
  • AAOIApplied Optoelectronics$62.38-9.7%
  • CRWVCoreWeave$49.85-9.2%

IDEXX Laboratories closed up 21.88%, the single largest move in a 383-name universe. Lumentum and Marvell sat at the other end of the session.

Read more
TEMTempus AI
Regular session
$83.26
+12.07%open $74.29

Tempus AI's Q3 earnings beat added roughly $1.5 billion of market value in one session. Whether the move holds through the close is the question for anyone still deciding on AI diagnostics.

Read more
Earnings CallEric P LefkofskyCEO and Chairman, Tempus AI, Inc.
Q3 was another record quarter, as we delivered $411.5 million of revenue, led by accelerating unit growth of 32% in our oncology business and increasing momentum of 33% revenue growth in Data & Applications.
5 days earlierSold TEM4

The selling came first: a Form 4 shows Lefkofsky unloading shares on October 29, five days before he stepped up to call the quarter a record. Insider sales ahead of good news are common at founder-led companies, but anyone owning this one should note the CEO was trimming into the strength he just described.

Read more
Earnings CallEric P LefkofskyCEO and Chairman, Tempus AI, Inc.
Q3 was another record quarter, as we delivered $411.5 million of revenue, led by accelerating unit growth of 32% in our oncology business and increasing momentum of 33% revenue growth in Data & Applications.
40 days earlierSold TEM4

Lefkofsky sold shares on September 24, five and a half weeks before stepping up to call the quarter a record, so the Form 4 came while he already had a line of sight on results. The words and the trade point in opposite directions, and insider timing is now part of the story for anyone buying the growth narrative at a $13.4 billion market cap.

Read more
TEMTempus AI
Q3 2026
EPS
$0.07
est -$0.08+$0.15
Revenue
$412M
est $409M+0.6%

Tempus AI turned its first adjusted profit, exceeding expectations that called for a loss, and raised full-year revenue guidance to roughly $1.6 billion.

Quarterly EPS — reported vs estimate
Read more
Earnings on deck — Nov 2–6
1301 companies521 before open780 after close

1,301 companies report next week, and Monday alone front-loads the read on consumer, travel and chips before the open: Estée Lauder, Marriott, Fox, Check Point and Tower Semiconductor. With misses getting punished harder than usual this season, positioning ahead of Monday morning matters.

  • CHKPCheck Point Software Technologies Ltd.Mon Nov 2Before open
  • TEMTempus AI, Inc. Mon Nov 2Before open
  • ELThe Estée Lauder Companies Inc.Mon Nov 2Before open
  • CIFRCipher Mining IncMon Nov 2Before open
  • ETREntergy CorporationMon Nov 2Before open
  • MARMarriott International, Inc.Mon Nov 2Before open
  • NSSCNAPCO Security Technologies, Inc.Mon Nov 2Before open
  • AKRAcadia Realty TrustMon Nov 2Before open
  • FOXAFox CorporationMon Nov 2Before open
  • PEGPublic Service Enterprise Group IncorporatedMon Nov 2Before open
  • TSEMTower Semiconductor Ltd.Mon Nov 2Before open
  • ALXAlexanders Inc.Mon Nov 2Before open
  • AXSMAxsome Therapeutics, Inc.Mon Nov 2Before open
  • CHHChoice Hotels International, Inc.Mon Nov 2Before open
  • CNACNA Financial CorporationMon Nov 2Before open
Read more
TEMTempus AI
After-hours
$71.98
-15.32%open $85.00

A 15.3% slide to $71.98 wipes roughly $2 billion off a $12.6 billion AI diagnostics name in a single session. Moves this big reset the whole trading range, so watch where it opens next.

Read more
Biggest movers · At the close
Gainers
  • CIENCiena$445.37+14.3%
  • CEGConstellation Energy$300.52+12.3%
  • FNFabrinet$488.18+7.6%
  • NBISNebius Group$250.1+7.5%
  • ALABAstera Labs$388.9+7.3%
Losers
  • TEMTempus AI$71.68-14.2%
  • STXSeagate Technology$806.34-9.1%
  • MRNAModerna$187.05-8.0%
  • APPSDigital Turbine$10.48-6.6%
  • SKHYSK hynix Inc.$182.3-6.5%

Nearly 29 points of spread separated the top and bottom of the board at Monday's close, with Ciena up 14.29% to $445.37 and Tempus AI down 14.21% to $71.68. Four of the five leaders sit in AI infrastructure names.

Read more
TEMTempus AI
Regular session
$74.22
-12.69%open $85.00

A 12.7% intraday slide to $74.22 strips roughly an eighth off a $13 billion market cap in a single session. Whether the $85 open gets reclaimed is the level to keep an eye on.

Read more
Biggest movers · At the close
Gainers
  • PBR-APetrobras$22.12+12.8%
  • PBRPetrobras$24.17+11.6%
  • MELIMercadoLibre$1,864.06+9.9%
  • TEMTempus AI$83.63+9.1%
  • FUTUFutu Holdings$110.05+7.7%
Losers
  • OPENOpendoor Technologies$2.33-4.7%
  • NBISNebius Group$232.87-4.1%
  • BMYBristol Myers Squibb$58.81-3.8%
  • NOKNokia$10.22-3.6%
  • GLWCorning$158.53-3.5%

Both Petrobras lines closed double digits higher, the only names in a 383-stock board to do it. MercadoLibre and Tempus AI each added more than 9%, while the worst loser gave up under 5%, so the upside skew was lopsided.

Read more

TEM Coverage

Load More

Frequently Asked Questions

What does Tempus AI do?

Tempus AI is a technology company applying artificial intelligence to precision medicine.

What is the TEM stock price target?

24/7 Wall St.'s 12-month price target for TEM is $87.95, rated Buy. The Wall Street consensus target is $80.61. TEM price prediction →